Celularity
Stock Forecast, Prediction & Price Target
Celularity Financial Estimates
Celularity Revenue Estimates
Celularity EBITDA Estimates
Celularity Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | |
Revenue
% change YoY
| $21.33M N/A | $17.97M -15.74% | $22.77M 26.68% | Avg: $65.53M Low: $65.53M High: $65.53M avg. 187.81% | Avg: $70.47M Low: $70.47M High: $70.47M avg. 7.52% | Avg: $285.65M Low: $285.65M High: $285.65M avg. 305.36% | |
Net Income
% change YoY
| $-100.11M N/A | $14.19M 114.17% | $-196.29M -1483.13% | Avg: $-99.58M Low: $-6.29M High: $-6.29M avg. 49.26% | Avg: $-68.92M Low: $-68.92M High: $-68.92M avg. 30.79% | Avg: $22.47M Low: $22.47M High: $22.47M avg. 132.60% | |
EBITDA
% change YoY
| $-96.92M N/A | $-141.13M -45.60% | $-183.94M -30.33% | Avg: $-27.25M Low: $-27.25M High: $-27.25M avg. 85.18% | Avg: $-29.31M Low: $-29.31M High: $-29.31M avg. -7.52% | Avg: $-118.81M Low: $-118.81M High: $-118.81M avg. -305.36% | |
EPS
% change YoY
| -$14.93 N/A | $1.01 106.76% | -$11.02 -1191.08% | Avg: -$0.42 Low: -$0.42 High: -$0.42 avg. 96.18% | Avg: -$4.6 Low: -$4.6 High: -$4.6 avg. -995.23% | Avg: $1.5 Low: $1.5 High: $1.5 avg. 132.60% | |
Operating Expenses
% change YoY
| $159.69M N/A | $146.57M -8.21% | $199.04M 35.79% | Avg: $134.89M Low: $134.89M High: $134.89M avg. -32.22% | Avg: $145.04M Low: $145.04M High: $145.04M avg. 7.52% | Avg: $587.94M Low: $587.94M High: $587.94M avg. 305.36% | |
FAQ
What is Celularity stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 70.88% in 2025-2027.
We have gathered data from 1 analysts. Their low estimate is -6.29M, average is -99.58M and high is -6.29M.
What is Celularity stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 166.89% in 2025-2027.
We have gathered data from 1 analysts. Their low revenue estimate is $65.53M, average is $65.53M and high is $65.53M.
What is Celularity stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of -255.48% in 2025-2027.
We have gathered data from 1 analysts. Their low earnings per share estimate is -$0.42, average is -$0.42 and high is $-0.42.
What is the best performing analyst?
In the last twelve months analysts have been covering Celularity stock. The most successful analyst is Asthika Goonewardene.